TY  - GEN
AU  - Ichikawa,Tomotsugu
AU  - Kurozumi,Kazuhiko
AU  - Michiue,Hiroyuki
AU  - Ishida,Joji
AU  - Maeda,Yoshinobu
AU  - Kondo,Eisei
AU  - Kawasaki,Akihiro
AU  - Date,Isao
TI  - Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma
SN  - 1872-6968
PY  - 2015///0803
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Central Nervous System Neoplasms
KW  - drug therapy
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Karnofsky Performance Status
KW  - Lymphoma
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Neuropsychological Tests
KW  - Prednisolone
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clineuro.2014.10.011
ER  -